Treprostinil dry powder inhaler (treprostinil)-Yutrepia dosage and usage

Treprostinil dry powder inhalation (treprostinil)-Yutrepia is a drug specially used to treat pulmonary arterial hypertension . Its usage and dosage need to be adjusted according to the specific conditions of the patient. The following are instructions for the dosage and usage of Yutrepia.

Yutrepia is for oral inhalation only and must be used with the inhaler provided and should not be swallowed. For treatment-naïve patients, the recommended starting dose is 26.5 mcg, 3 to 5 inhalations per day, taking 2 breaths each time. This dose can be adjusted based on patient response.

For those patients transitioning from treprostinil inhalation solution (Tyvaso) to Yutrepia, the dose should be adjusted based on the patient's current Tyvaso use. Table 1 lists the Yutrepia doses corresponding to different Tyvaso usage frequencies:

CurrentYutrepia dose is 26.5 mcg when Tyvaso dose is 5 breaths or less;

The corresponding dose of Yutrepia for 6 to 8 breaths is 53 micrograms;

79.5 micrograms at 9 to 11 breaths;

106 micrograms in 12 to 14 breaths;

32.5 micrograms in 15 to 17 breaths;

159 micrograms in 18 or more breaths.

For patients who are new to treprostinil or transitional patients, the dose can be increased by 26.5 micrograms per week if tolerated, with a target maintenance dose of 79.5 micrograms to 106 micrograms, inhaled 4 times a day. It should be noted that doses above 848 mcg per day have not been studied in patients with PAH, so caution is recommended in use.

If a patient misses a scheduled dose, the regular dose should be resumed as soon as possible, but the dose should not be repeated or increased within the same day. Following the physician's guidance and regularly monitoring medication effects and side effects can help patients better manage their disease and improve their quality of life. Patients should understand the usage and dosage information when using Yutrepia so that treatment can be carried out safely and effectively.

Reference materials:https://www.drugs.com/pro/yutrepia.html